gene_symbol
CD19
hgnc_id
HGNC:1633
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Blinatumomab bridges CD19 on target cells to CD3 on T cells, forming an immunological synapse and triggering T‑cell–mediated killing (perforin/granzyme and Fas–FasL apoptosis) of CD19+ cells.
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
B-cell surface antigen
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT05865301
disease_id_num_tar_ref
5289
drug_id_num_tar_ref
14388